Trending Topic

22 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

This systematic review and meta-analysis investigate the efficacy of teprotumumab, a novel monoclonal antibody, in reducing proptosis for patients with long-duration thyroid eye disease (TED). While teprotumumab has shown promise in treating active TED, its effectiveness in chronic cases remained less certain. By synthesizing data from nine individual studies, this meta-analysis aimed to quantify the […]

< 1 min

EASD 2024 – 60th EASD Annual Meeting – 9 – 13 September, Madrid Spain

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 5th 2024

We’re looking forward to the 60th anniversary of the EASD Annual Meeting 2024, which is taking place in Madrid between 9-13 September 2024.

Promising attendees an opportunity to explore the latest technologies, treatments, and products in the field of diabetes, we are excited to provide independent, expert video coverage of key data.

You can sign-up here to receive all our EASD 2024 content or follow the congress on social media using #EASD2024

Soon we’ll be sharing our exclusive interviews with industry experts, but in the meantime – explore our collection of video interviews here

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied

This Functionality is for
Members Only

Explore the latest in medical education and stay current in your field. Create a free account to track your learning.

Close Popup